Assenagon Asset Management S.A. Lowers Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Assenagon Asset Management S.A. cut its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 55.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 432,714 shares of the company’s stock after selling 541,077 shares during the period. Assenagon Asset Management S.A. owned 0.17% of Oscar Health worth $5,816,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new stake in Oscar Health during the second quarter worth $78,000. KBC Group NV lifted its holdings in Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares in the last quarter. ORG Wealth Partners LLC purchased a new position in Oscar Health during the fourth quarter valued at $100,000. Amalgamated Bank lifted its holdings in Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new position in Oscar Health during the third quarter valued at $142,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $15.92 on Tuesday. The firm has a 50-day simple moving average of $15.03 and a 200-day simple moving average of $16.83. The stock has a market capitalization of $3.94 billion, a price-to-earnings ratio of -265.26, a price-to-earnings-growth ratio of 0.57 and a beta of 1.70. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.45 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.29) earnings per share. On average, equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was acquired at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the transaction, the director now directly owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of the company’s stock in a transaction on Monday, November 11th. The shares were bought at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

Analyst Ratings Changes

OSCR has been the topic of several recent analyst reports. Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. UBS Group initiated coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock. Finally, Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.